Hoth Therapeutics Inc
Research Hoth Therapeutics Inc (HOTH) on Bullrun: market cap USD 20.66M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHOTH
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 20.66M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 2.69M
- Free cash flow-USD 3.05M
Valuation Snapshot
latest market cap is USD 20.66M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 12.47M | -USD 9.80M | n/a | -0.9 | USD 6.25M | USD 5.68K | USD 6.15M |
| FY2024 | USD 0 | -USD 8.19M | -USD 6.98M | n/a | -1.28 | USD 7.04M | USD 31.08K | USD 6.88M |
| FY2023 | USD 0 | -USD 8.11M | -USD 8.45M | n/a | -2.38 | USD 9.29M | USD 55.17K | USD 9.54M |
| FY2022 | USD 0 | -USD 11.37M | -USD 9.37M | n/a | -9.5 | USD 6.43M | USD 0 | USD 6.11M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-06-18 | USD 20.66M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 15.36M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 6.03M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 6.26M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 10.14M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 15.82M | n/a | n/a | n/a |
About Hoth Therapeutics Inc
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs in the United States. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Hoth Therapeutics Inc's market cap?
Hoth Therapeutics Inc's market capitalization is USD 20.66M.
What does Hoth Therapeutics Inc do?
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs in the United States.